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ABSTRACT 
 
The Effects of Bio-Mos on Lamb Growth and Immune Function. (August 2007) 
 
Jeffrey Thomas Thayne, B.S., Texas A&M University 
 
Co-Chairs of Advisory Committee: Dr. S. Ramsey 
                                                                                         Dr. J. Sawyer 
 
 
 The objective of this study was to evaluate the effects of inclusion of Bio-Mos in 
the growing ration for weaned lambs on growth rate, feed efficiency, and clinical 
measures of health of the lambs.  Mannan oligosaccharides (MOS), when included as a 
supplement to the diet, have been shown to have a positive effect on immune response in 
several species and in turn, positively affect the growth of the animal.  MOS are 
commercially available as BioMos®, which is a nutritional supplement manufactured by 
Alltech, Inc. out of Nicholasville, KY.  Forty-seven weaned Suffolk × Hampshire (n=47) 
lambs were used in this trial. Of the group, twenty (n=20) were ewe lambs and twenty-
seven (n=27) were wether lambs.  The lambs were placed on their assigned diets and 
remained on the trial for a four week period (d+28).  All responses evaluated in this study 
were influenced by time (p < 0.05) over the 28-d trial.    A GENDER × WEEK 
interaction was observed for ADG and feed conversion (p < 0.05). Control lambs tended 
(p = 0.10) to have a higher intake over the 28-d period in comparison to Bio-Mos fed 
lambs.  There were no statistically significant differences (p < 0.05) between control and 
Bio-Mos fed lambs for any of the growth parameters that were measured. There was a 
tendency (p = 0.10) for GENDER × WEEK to influence intake. Gender also tended to 
interacted with diet (GENDER × DIET, p = 0.09) to influence intake over the trial period. 
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A GENDER × WEEK interaction was observed (p < 0.05) for feed conversion.  Diet 
influenced fecal pH (p < 0.05). This study indicates Bio-Mos had minimal influence on 
growth and health. 
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INTRODUCTION 
 
 
Mannan oligosaccharides (MOS), when included as a supplement to the diet, have 
been shown to have a positive effect on immune response in several species and in turn, 
positively affect the growth of the animal.  Mannan oligosaccharides are indigestible 
complex polysaccharide molecules derived from the cell wall of the yeast Saccharomyces 
cerevisiae, with approximately 45% of the cell wall consisting of mannose residues 
(Tizard et al., 1989).  Mannan oligosaccharides are commercially available as BioMos®, 
a nutritional supplement manufactured by Alltech, Inc. (Nicholasville, KY).  Mannan 
oligosaccharides have been reported to provide binding sites for enteric pathogenic 
bacteria, presumably reducing pathogen binding.  Certain bacteria have a binding 
preference for certain carbohydrates and when these carbohydrates are included in the 
diet, specific intestinal bacteria will affix to the carbohydrate and cross the wall of the gut 
in the digestive process.  The addition of MOS to the diet provides an alternate mannose 
binding site for bacteria, because MOS is not digestible, bacteria exit the digestive tract 
attached to the MOS.  MOS have been shown to elicit a positive response on the immune 
system as well as serving as alternate attachment sites in the gut for gram-negative 
pathogenic organisms with mannose-specific type-1 fimbriae that adhere to intestinal 
epithelial cells to initiate disease (Ferket et al., 2002).   Previous studies have 
demonstrated MOS reduces in vitro attachment of Salmonella typhimurium to cultured  
__________ 
This thesis follows the style of Journal of Animal Science. 
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intestinal cells (Oyofo et al., 1989) and decreases fecal concentrations of Clostridium 
perfringens in poultry (Finuance et al., 1999).  Different in vitro studies have 
demonstrated agglutination of Escherichia coli, Salmonella typhimurium and S. 
enteritidis in the presence of MOS (Spring et al., 2000).  These compounds have also 
been reported to stimulate antibody production and influence gut morphological 
development in young animals.  Supplemental MOS in poultry diets increased both 
plasma IgG and bile IgA (Savage et al., 1996).  Mannan oligosaccharide supplementation 
increased serum IgM and tended to increase colostral IgG levels in sows (Newman and 
Newman, 2001).  In dogs supplemented with MOS, total lymphocyte count was 
increased, and serum IgA concentrations tended to be greater (Swanson et al., 2002).  
Non-prescription use of antibiotics in livestock feeds has been eliminated or 
severely limited in many countries because of consumer perception issues and concerns 
related to the development of antibiotic resistant human pathogenic bacteria. Therefore, 
alternatives to antibiotics are being investigated by those interested in the livestock 
industry.  Most of the previous research involving MOS has investigated the positive 
performance benefits seen with the use of a MOS addition to production diets.  Studies 
have demonstrated that the addition of MOS to the diet results in increased average daily 
gain of broilers (Hooge, 2003), increased gain-to-feed ratio of growing/finishing pigs 
(Davis et al., 2002), and heavier litter birth and weaning weights in swine  (O’Quinn et 
al., 2001).  The immune response elicited by MOS supplementation in swine, poultry, 
and cattle has recently begun to be investigated.  Comparatively, little research has been 
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involved in lamb performance and immune response with the addition of MOS to the 
production diet. 
These potential effects suggest that Bio-Mos may improve productivity of newly 
weaned growing lambs placed on an intensive growing program. Improved growth rate 
may result from improved health status or enhanced nutrient absorption due to gut 
development. However, fewer trials have directly evaluated performance of lambs in this 
production setting.  The enhancement of performance and conversion rate combined with 
the reduced occurrence of diarrhea and other problems caused by these organisms in 
weaned lambs would result in healthier lambs and decreased financial loss due to 
veterinary expenses associated with lamb production.  The objectives of this study are to 
evaluate the impacts of the mannan oligosaccharide Bio-Mos® on measures of lamb 
growth performance, efficiency, and health in an intensive growing program.  
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LITERATURE REVIEW 
 
Lamb Growth 
 
 The importance of growth performance in the production of livestock cannot be 
underestimated.  A key in the production of lambs is the added value gained by lambs 
offering more pay-weight.  The ability to add this weight with a least cost and feed 
efficient formula is ultimately a key factor in profitability.  Growth usually is defined as 
the production of new cells.  But because growth is typically measured as an increase in 
mass, growth includes not only cell multiplication (hyperplasia) but also cell enlargement 
(hypertrophy) and incorporation of specific components from the environment (e.g., 
apatite deposition) (Owens et al., 1993).  Following weaning, the practice of removing 
lambs from the milk diet provided by the ewe, lambs at this young state or age are 
typically fed in a drylot utilizing a concentrated grain diet.  This separation can be 
stressful for both ewes and lambs.  During the post-weaning period, the young lamb is 
undergoing many stressors and is susceptible to disease challenges and the presence of 
bacteria such as E. coli.  A central feature of stress is the release of adrenocorticotropic 
hormone (ACTH) from the anterior pituitary, which regulates cortisol secretion by the 
adrenal glands. The pituitary-adrenal response is stimulated typically by emotional 
perturbations such as uncertainty or social dislocation (Dantzer and Morme`de, 1985).  
Social dislocation, such as weaning, elicits a stress response characterized by adaptive 
behaviors that may be quantified to assess the degree of stress.  Excessive weaning stress 
may affect appetite, metabolism, and immune competence. Another feature of stress is 
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increased demand for ascorbic acid (Newberne and Conner, 1989).  These health 
problems may, in turn, affect the growth of the lamb.  In an attempt to halt lost 
performance due to disease, historically antibiotics have been added to the lamb’s diet.  
The awareness of potential resistance and the interest in finding alternatives to antibiotic 
growth promoters, has led to the investigation of the efficacy of mannanoligosaccharides 
in this situation. 
 Growth usually is defined as production of new cells.  But because growth 
typically is measured as an increase in mass, growth includes not only cell multiplication 
(hyperplasia) but also cell enlargement (hypertrophy) and incorporation of specific 
components from the environment.   By definition, growth includes deposition of fat even 
though muscle mass is of primary interest in meat production (Owens et al., 1993).  
Growth and health of the animals are the primary focus of livestock producers.  The 
ability to add tissue mass in the form of protein accretion in a fast and efficient manner is 
sought using many different additives and feedstuffs. 
 Energy intake can exceed genetic potential for lean tissue accretion rate.  Rouse et 
al. (1970) reported the order of tissue maturation to be bone, lean, and fat.  This also 
represents tissue priority for nutrients until the tissue is mature (Byers et al., 1988).  
Byers et al. (1988) also suggested that as ADG increases, protein deposition increases at 
decreasing rates, whereas fat deposition increases at increasing rates.  This suggests 
reduced energy intake would lead to reductions in accretion rates of protein as well as fat, 
but at different levels. 
 In an attempt to add this tissue mass onto the animal, many different methods of 
promoting growth have been utilized within the industry.  Animals can be fed in a pasture 
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setting or in drylot, fed ad libitum or restricted, and animals can be supplemented or not.  
The question of how to present and develop the diet for growing animals is one that has 
been investigated extensively in the animal science industry. 
 Huston et al. (1990) investigated the use of ionophore supplements to lambs and 
Angora kid goats on rangeland.  These authors stated that weaned offspring of ruminant 
livestock species normally have fully functional reticuloruminal microbial populations to 
digest forage.  However, range forages may not contain certain nutrients in sufficient 
concentrations to support adequate growth and development of young animals having 
high requirements.  Overall, ionophores had minimal effects on the response criteria.  
Because feed intake and digestibility were not affected, any increase in gain or efficiency 
in lambs or kid goats on rangeland from consumption of ionophores was considered a 
result of their therapeutic value or of improved physiological efficiency. 
Drylot 
 
 More recent research has shown daily accretion of carcass lean and fat was 
greater for lambs fed all-concentrate diets than for lambs grazed on cool-season grasses 
or alfalfa (Murphy et al., 1994).  Feeding systems that promote rapid lamb growth, such 
as concentrates fed in drylot, usually result in greater efficiency (gain/feed; McClure et 
al., 1994).  In a three-year study by these same authors, feed efficiency of lambs fed in 
drylot was 219, 237, and 206 g of gain/kg of feed in 1983, 1984, and 1985, respectively.  
This level of efficiency was similar to that reported by Notter et al. (1991) when lambs of 
a comparable age were fed similar diets. McClure et al. (1994) observed that growth and 
body condition scores of lambs were greatest for lambs fed in drylot (ADG = 257 g, BCS 
= 12.2), as compared to those grazed on alfalfa(ADG = 220 g, BCS = 10.3), 
  
 7 
 
 
 
 
orchardgrass(ADG =127 g, BCS = 8.4), and perennial ryegrass(ADG = 129 g, BCS = 
8.4), indicating that forage-fed lambs have lower daily gains and lighter carcasses than 
concentrate-fed lambs.  Lower carcass weights result because quantity of carcass fat is 
reduced for lambs grazing alfalfa.  Lambs finished on grass pastures have poorer 
performance and carcass composition with less muscle, fat, and bone than lambs finished 
on concentrate diets.  
Ad libitum Feeding Regimen 
 Sheep grown for meat production are usually given ad libitum access to feed to 
maximize rate of gain and, presumably, feed efficiency because maintenance cost is 
diluted.  The most common difficulty with ad libitum intake is that daily intake may 
fluctuate greatly; resulting in digestive disturbances and potentially decreased 
performance in lambs fed high-concentrate diets (Hart and Glimp, 1991).  In studies 
summarized by Hicks et al. (1987), restricting intake of beef cattle by an average of 8.7% 
below ad libitum reduced daily gain 5.2% and improved feed efficiency 3.2%.  Glimp et 
al. (1989) observed a 20% improvement in feed efficiency of lambs by restricting intake 
to 92.5% of ad libitum.  Rate of gain was improved by the restriction and accounted for 
much of the improved feed efficiency.  This improvement in rate of gain is not due to 
increased diet digestibility but some other mechanism, possibly a more stable gut 
environment.  Further restriction to 85% of ad libitum reduced rate of gain by 7%, but 
feed efficiency was improved by 7% compared with animals with ad libitum intake.  Old 
and Garrett (1987) observed a 20% improvement in feed efficiency by steers fed to gain 
85% as fast as those fed for ad libitum intake.  Anderson (1975) observed that bulls 
gained more efficiently when fed at 85% of ad libitum intake than when fed ad libitum. 
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 However in a conflicting study, the investigators reported restricting daily dry 
matter intake by 15 and 30% leads to lower average daily gain.  This reduction in ADG 
seems to be due to restrictions in fat accretion rates in lambs that are limit-fed (Murphy et 
al. 1994).  These authors also found restricted feeding of concentrate diets provides 
adequate energy to achieve maximal lean tissue accretion but reduces daily fat accretion.  
Average daily gain decreased linearly with decreasing intake (Murphy et al., 1994).  
Andrews and Orskov (1970) also reported decreased ADG in lambs with decreasing 
intake level. 
Feed Additives 
Antibiotics.  Antibiotics have been used as feed additives in the swine industry for 
over 50 years as growth promotants and for therapeutic treatment of disease.  The 
benefits of antibiotics in improving growth, reducing mortality and morbidity, and 
improving reproductive performance are well documented in numerous research studies 
(Hays, 1981; Cromwell, 2001).  The discovery that antibiotics improved growth and feed 
efficiency led to widespread prophylactic antibiotic use (Visek, 1978), which continues in 
situations in which undiagnosed or subclinical systemic infections could limit growth and 
feed efficiency (Gustafson and Bowen, 1997).   The use of antibiotics for prophylaxis is 
utilized within the industry, however these methods differ from products that are 
associated with changing ruminal fermentation profiles such as ionophores.   
 Use of antibiotics in animal production may contribute to antibiotic resistance of 
human pathogens such as salmonellae due to resistance of resistance to ceftriaxone and 
the fluoroquinolones (Fey et al., 2000).  As a result interest in alternatives for antibiotics 
is strong.  Some potential replacements include plasma proteins (Morrill et al., 1995; 
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Quigley and Drew, 2000), probiotic bacteria (Jenny et al., 1991) or yeast cultures 
(Seymour et al., 1995), and oligosaccharides (Kaufhold et al., 2000; Donovan et al., 
2002; Quigley et al., 2002).   
Ionophores.  Monensin is an ionophore that was first used as a coccidiostat in 
poultry and was then applied to ruminants from the mid-1970s onward.  It provides an 
economic benefit in terms of feed efficiency (an average 7.5% improvement; Goodrich et 
al., 1984), at least partly via its effect on ruminal fermentation (Wallace, 1994).  Several 
other ionophores have been identified that provide similar benefits, including lasalocid, 
salinomycin, lysocellin, narasin, tetronasin, and the peptide antibiotic avoparcin.  The 
toxicity of ionophores stems from their ability to translocate ions across biological 
membranes and consequently to disrupt transmembrane ion gradients (Bergen and Bates, 
1984).  Not all microorganisms are affected by ionophores: monensin and similar 
ionophores inhibit Gram-positive bacteria more than Gram-negative bacteria (Chen and 
Wolin, 1979).  This selectivity is central to their manipulative effect, and depends on the 
permeability of the cell envelope (cell wall and outer membrane in Gram-negative 
bacteria, cell wall in Gram-positive bacteria) (Wallace, 1994).  These authors also stated 
the effects that ionophores had on fermentation, such as changed fermentation 
stoichiometry and improved protein flow from the rumen, are in many ways consistent 
with their effects on the bacterial population. 
 In grazing studies, ionophores in supplemental feeds have had inconsistent effects 
on intake and weight change by cattle (Huston and Spiller, 1981).  Monensin appeared to 
increase gain and (or) improve digestibility of forage as a result of an increased 
gastrointestinal fill and a decreased turnover rate of ruminal digesta (Ellis et al., 1981).  
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Huston et al. (1990) performed a study that involved 12 dietary treatments including a 
negative control (grazed forage only), positive control (grazing plus milo/cottonseed meal 
supplement), and a positive control with either monensin or lasalocid, with each at 33, 66, 
99, 132, 165 mg/kg in the supplement.  The authors found the effects of ionophore 
feeding on gastrointestinal retention time and turnover rate parameters were minimal and 
appeared without consequence.  Hence, any improvement in growth rate and (or) 
efficiency from ionophore feeding must be the result of either treatment effects or 
improved physiological efficiency.  In this study, weight gain was not different for sheep 
vs. goats, but was increased in both species by supplementation (sheep NC=44 g/d vs. 
goats NC=54 g/d; sheep PC=71 vs. goats PC=92g/d; sheep MON 33=106 g/d vs. goats 
MON 33=114 g/d; sheep MON 66=78 g/d vs. goats MON 66=108 g/d). 
Yeast.  Live microbial cultures and their extracts, particularly of Aspergillus 
oryzae and Saccharomyces cerevisiae, have been used as feed additives for many years.  
Their widespread use as manipulating agents for ruminal fermentation, so-called direct-
fed microbials, is well documented (Wallace, 1994).  On average, published data 
indicated microbial additives may benefit ruminant nutrition (in terms of live weight gain 
and milk production) by a similar magnitude to ionophores (7 or 8% improvement; 
Wallace and Newbold, 1993), in this case by increasing feed intake rather than feed 
efficiency (Williams and Newbold, 1990). 
The efficiency of the rumen may be enhanced by microbial feed additives altering 
the products of fermentation.  Live yeast cultures provide many substrates for bacteria 
growth, including B vitamins, amino acids, and other organic acids.  The benefits of 
supplementing yeast products may be due to the utilization of metabolites or to the 
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interaction of the yeast and rumen microbes.  Yeast supplements are expected to elicit the 
greatest response in times of stress.  During times of stress, including growth stages, 
animals have higher nutrient requirements (Arambel, 1988).  Phillips and von Tungelin 
(1985) fed yeast culture to post-stressed heifers and steers for four weeks.  Cattle 
receiving the yeast supplement had greater DMI and an increase in ADG compared to 
cattle receiving control treatments.  A study by Chaucjeyras-Durand and Fonty (2001) 
showed the inclusion of yeast in diets fed to gnotobiotically-reared lambs may have 
increased the rate at which cellulolytic bacterial species propagated in the rumen.  The 
authors suggested this increase of growth rate was due to the ability of viable yeast cells 
to scavenge oxygen from the rumen.  Cellulolytic species are extremely oxygen sensitive.  
Cellulolytic species deceased when the rumens of these lambs were exposed to oxygen 
during fitting of the cannula.  The cellulolytic population remained stable in the rumens 
of the lambs fed a yeast supplement. 
 Yeast supplementation has been shown to alter ruminal VFA production and 
concentrations, including affecting acetate to propionate ratios and decreasing methane 
production.  Enjalbert et al. (1999) showed an increase in the molar percentage of 
propionate and a decrease in the acetate to propionate ratio (A:P).  Investigators have 
published conflicting reports in regard to changes in VFAs.  Piva et al. (1993) showed no 
significant differences in VFA, but acetate and A:P tended to be higher in cows 
supplemented with yeast.  In contrast, Harrison et al. (1988) found cows fed a yeast 
supplement had a higher molar propionate level and lower molar acetate, resulting in a 
decreased A:P.  In the same study, yeast supplementation increased concentrations of 
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branched chain acids (isobutyrate, isovalerate, and valerate).  These authors concluded 
that yeast serves to stabilize rumen fermentation.   
Quigley et al. (1992) found yeast supplementation may also affect lactate 
production in the rumen.  Jersey calves were fed experimental diets with the inclusion of 
either sodium bicarbonate or yeast.  Calves fed yeast cells had decreased amounts of 
ruminal lactate at 4 h post-feeding.  Plasma lactate declined with feeding, but tended to 
be lower when calves were fed yeast compared to bicarbonate. 
Effects of yeast supplementation on health status.  Seymour et al. (1995) 
suggested that yeast has a beneficial effect on the overall gut health of dairy calves.  
These authors reported yeast had a positive effect on fecal scores as well as feed to gain 
ratio.  Data were recorded on a scale of 1 to 4, with 1 being normal and 4 being fecal 
scours.  During the transition from milk replacer to dry feed, calves fed yeast had a lower 
DMI, but showed a better feed to gain ratio, indicating the yeast may have helped the 
calves adapt to dry feed.  In period 3, after transition to dry feed, calves fed yeast showed 
a lower percentage of fecal scours and a lower incidence of abnormal body temperatures.  
The authors speculated that Cr supplied by the yeast may have improved the immune 
response; however, Cr was not assayed. 
Mannan oligosaccharides.  Carbohydrates are the most abundant biological 
molecules, and fill numerous roles in living things, including the storage and transport of 
energy and structural components. Additionally, carbohydrates and their derivatives play 
major roles in the functioning of the immune system, fertilization, pathogenesis, blood 
clotting, and development.  Carbohydrates are important structural components of the 
majority of cell-surface and secreted proteins of animal cells (Osborn and Khan, 2000).  
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Carbohydrates are also a major source of metabolizable energy in the diet.  
Oligosaccharides are made from isomerization of disaccharides, enzymatic hydrolysis of 
polysaccharides, or by direct extraction from the cell wall of yeasts.  The type of carbon 
backbone to which they adhere typically classifies these structures.  Mannose is a 
monosaccharide that forms the building block of MOS.  The small intestine does not 
contain the digestive enzymes required to break down mannan oligosaccharide bonds, 
and therefore they arrive at the large intestine intact after ingestion and passage through 
the small intestine (Strickling et al., 2000).  Mannose-based oligosaccharides occur 
naturally in cells walls of the yeast Saccharomyces cerevisiae and are relatively easy to 
obtain by centrifugation from a lysed yeast culture (Spring et al., 2000).  The 
commercially available product Bio-Mos® (Alltech, Inc., Nicholasville, KY) is a source 
of MOS from Saccharomyces cerevisiae cell walls.  This product was introduced in 1993 
as a feed additive for broiler chickens (Hooge, 2003).  Bio-Mos® has shown promise in 
suppressing enteric pathogens, modulating the immune response, improving the integrity 
of the intestinal mucosa, and promoting improved growth and feed conversion in studies 
with chickens and turkeys (Olsen, 1996; Spring, 1999a, 1999b; Iji et al., 2001; Sonmez 
and Eren, 1999; Spring et al., 2000; Savage and Zakrzewska, 1997; Valancony et al., 
2001). 
 Much of the negative perception concerning oligosaccharides, or more 
specifically, soy oligosaccharides, stems from assumed depression in nutrient 
digestibilities and the increase in gas production resulting from fermentation of these 
substrates (Hata et al., 1991).  Intestinal gases (H2, CO2, and CH4) originate from colonic 
fermentation of the nondigestible oligosaccharides, raffinose, and stachyose (Delzenne 
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and Roberfroid, 1994).  Yet oligosaccharide fermentation also yields products that are 
beneficial to the host, namely the short-chain fatty acids acetate, propionate, and butyrate 
(Buddington, 2001).   
 In a study by Smiricky-Tjardes et al. (2003) investigating the fermentation 
characteristics of oligosaccharides in swine fecal microflora, mannan oligosaccharides 
were studied for gas production, pH, and short chain fatty acid production.  Mannan 
oligosaccharide fermentation resulted in the lowest quantity of gas production, the lowest 
rate of gas production, and the longest time to attain maximal rate of gas production.  
This is coupled with high pH and low SCFA production.  Unlike most of the 
oligosaccharides tested in the experiment, mannan oligosaccharide is a crude extract from 
yeast and contains 6% N, 41% total dietary fiber, 8% fat, and 44% total monosaccharides 
on a dry matter basis.  Therefore, ingredients that do not ferment as rapidly, such as N 
and fat, could potentially inhibit fermentation.  Additionally, the fiber component of 
mannanoligosaccharides could slow its fermentability.  In this same study, fermentation 
of mannanoligosaccharides resulted in less production of SCFA when compared to all 
other substrates (fructooligosaccharides, raffinose, stachyose, soy solubles, granular and 
liquid forms of transgalactooligosaccharides, glucooligosaccharides, 
mannanoligosaccharides, and xylooligosaccharides) except for raffinose.  Also, rate of 
SCFA production was lowest for mannanoligosaccharides, indicating a lower 
fermentative capacity.  In agreement with this data, Vickers et al. (2001) reported 
substantially lower acetate (0.89 vs. 2.3 mmol/g of OM sample), propionate (0.3 vs. 0.9 
mmol/g of OM sample), and butyrate (0.2 vs. 0.3 mmol/g of OM) values when 
mannanoligosaccharide was fermented for 12 h when compared to short-chain 
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fructooligosaccharides.  This may explain why mannan oligosaccharides still have some 
binding effect in the lower gut, and the portions that are fermented may increase the 
nutrient supply or alter fermentation profiles which would result in positive performance 
effects. 
 Mannan oligosaccharides have improved performance in nursery pigs (Dvorak 
and Jacques, 1998) and weight gain and grain intake in dairy calves (Dvorak and Jacques, 
1997).  In addition, investigation continues into the potential relationship between 
oligosaccharides and human intestinal function (Jenkins et al., 1999) and their role in 
modulation of human gastrointestinal microflora (Gibson, 1999). 
 Mannans on the cell surface are the primary antigenic components of whole yeast 
cells and cell walls (Ballou, 1970).  Because many gram-negative bacteria attach to the 
intestinal epithelium using mannose-specific fimbriae (Ofek et al., 1977), MOS provides 
competitive binding sites for these intestinal pathogens.  Multiple strains of Escherichia 
coli and Salmonella agglutinated MOS in vitro (Spring et al., 2000).  The MOS is not 
enzymatically digested in the small intestine; therefore, bacteria bound to MOS likely 
exit the intestine without attaching to the epithelium (Spring et al., 2000).  Mannan 
oligosaccharides may also enhance health by stimulating antibody production (Savage et 
al., 1996) or by affecting intestinal morphology and function (Iji et al., 2001).  Inhibition 
of the bacteria responsible for toxin production could prevent or decrease the severity of 
diarrhea (Giannella, 1983). 
Growth Performance  
 The use of antibiotics in food animal diets is a known and common practice 
throughout the industry.  Antibiotics have been shown to improve growth, feed 
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efficiency, and overall herd health when used in poultry, swine, and cattle production 
diets.  Due to increasing regulatory restrictions based on consumer concerns, producers 
have begun the search for substances to replace the use of antibiotic growth promotants in 
production diets.  Mannan oligosaccharide supplementation has been and continues to be 
investigated as an alternative to antibiotic supplementation to improve performance traits. 
Cattle.  The effects of MOS supplementation in cattle diets has received less 
attention relative to production-enhancements effects of poultry and swine supplemented 
diets.  Heinrichs et al. (2003) investigated the effects of MOS or antibiotics in dairy calf 
milk replacer diets, and found the addition of 4 g MOS/day was as effective as antibiotic 
use to maintain normal fecal fluidity and consistency and to decrease scours severity.  
Addition of MOS or antibiotics increased the probability of normal scores for fecal 
fluidity, scours severity, and fecal consistency as compared to controls over the course of 
the study.  Feed consumption increased when MOS was included in the diet, but this did 
not result in a difference in growth measures (Heinrichs et al., 2003).  In this study, 
calves were fed to an age of six weeks. The gut morphology of neonatal calves (as during 
the time period of this trial) allows feed to bypass the rumen, therefore this study may not 
be indicative of a true ruminant trial. 
Broilers.  Waldroup et al. (2003) conducted a study to evaluate the effects of 
combinations of antibiotics, mannan oligosaccharides, and organic forms of copper in the 
diet of broilers.  These authors found that overall, Bio-Mos® had no significant effect on 
feed conversion but interacted with some of the other factors.  At 21 d there was an 
interaction between the antibiotic program and the inclusion of Bio-Mos®; adding Bio-
Mos® in the absence of antibiotics tended to improve feed conversion while adding Bio-
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Mos® in the presence of antibiotics tended to decrease feed conversion.  Lack of 
response to antibiotics in later stages of growth suggests that the birds were performing 
well with minimal stress, and perhaps is the reason for the lack of response to Bio-Mos® 
or to the copper sources.  It is also possible that the levels of Bio-Mos® used in this study 
were not sufficient to elicit a positive response.   
Turkeys.  Fritts and Waldroup (2003) investigated the use of Bio-Mos® as a 
potential replacement for growth promoting antibiotics in the diet of growing turkeys.  
Body weight, mortality, breast meat yield, and intestinal breaking strength were not 
significantly influenced by dietary treatments.  Feed conversion from 0 to 20 wk of age 
was significantly improved by Bio-Mos®.  This study is in agreement with the findings 
of Olsen (1996), and Savage and Zakrzewska (1997).  
Swine.   Though results have been somewhat inconsistent, some research suggests 
MOS may improve growth performance in young pigs (Davis et al., 1999; Pettigrew, 
2000).  White et al. (2002) investigated the use of brewers dried yeast as a source of 
mannan oligosaccharides in the diets for young pigs.  Results indicated growth 
performance was not enhanced by supplementing the basal diet with brewers dried yeast.  
Pigs fed the two yeast-containing diets consumed less feed, which resulted in reduced 
growth rates over the 28-d test period.  Feed:gain ratios tended to be inferior in the yeast-
fed pigs during the initial phase of the experiment. 
Immunity 
Swine. White et al. (2002) reported serum protein levels, a general indication of 
immune status, were not different among the dietary treatment groups at the end of a 28-d 
study.  Pigs fed yeast tended to have higher levels of IgG and IgA levels at study 
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termination, but the differences were significant only at p < 0.15.  Fecal pH and VFA 
concentrations were determined by the authors because they are indicative of 
fermentation patterns.  However, only minor changes in fecal pH and VFA 
concentrations occurred in the feces of pigs fed the different diets.  
Cattle. Franklin et al. (2005) concluded supplementation of MOS to dry cows 
resulted in enhanced response by the cows to immunization against rotavirus and a 
tendency for enhanced concentrations of rotavirus antibodies in the serum of calves.  
Supplementation of cows with MOS during the dry period may enhance transfer to the 
offspring of passive immunity against specific organisms, which may result in decreased 
use of therapeutic antibiotics in calves.  In the case of viral pathogens, where antibiotics 
are not as effective even though commonly administered to calves with diarrhea, the 
supplementation of MOS to dry cows to enhance transfer of passive immunity to calves 
may lead to decreased morbidity and medical treatments for calves. 
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RATIONALE 
 The ability of Bio-Mos® to enhance the productivity of different livestock species 
in several stages of production makes it an attractive option as a supplement to the diet 
throughout the livestock industry.  Sheep producers are interested in the health and 
performance of weaned lambs, and the ability of Bio-Mos® to stimulate antibody 
production, influence absorption and binding of enteric pathogens, serve as a gut 
buffering agent, and alter fermentation profiles could prove to be a viable option.  
Improved growth rate of the lambs could be a function of enhanced health status or gut 
function or gut health.  The capacity of Bio-Mos® to improve the health status, 
efficiency, and growth rate of weaned lambs needs to be investigated further. 
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HYPOTHESIS 
 The addition of Bio-Mos® to a weaned lamb diet should increase daily gain and 
enhance feed efficiency due to an improvement in the health status and immune function 
of the lambs during this period of high stress, and potentially through alterations in 
ruminal function that stabilize or enhance intake patterns and reduce digestive 
disturbances.  
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OBJECTIVES 
 The objective of the study was to evaluate the effect of inclusion of Bio-Mos® in 
the growing ration for weaned lambs on growth rate, feed efficiency, and clinical 
measures of health.  
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MATERIALS AND METHODS 
Animals 
 Forty-seven weaned Suffolk × Hampshire (n=47) lambs were used in this trial.  
Lambs were obtained from the Texas A&M University Sheep and Goat Center, and 
experimental procedures were approved by the Texas A&M University Institutional 
Animal Care and Use Committee, Animal Use Protocol number 2007-25.  Within gender, 
lambs were stratified by body weight and randomly assigned within strata to one of two 
dietary treatments.  The lambs ranged from 69 to 92 days of age at the start of the trial.  
Of the group, twenty (n=20) were ewe lambs and twenty-seven (n=27) were wether 
lambs.  The lambs were placed on their assigned diets and remained on the trial for a four 
week period (d=28).   
Housing and Management 
 During the course of the trial, the lambs were housed at the Texas A & M 
University Sheep and Goat Center 8.05 km west of College Station, Texas.  The lambs 
were housed in soil-surfaced pens equipped with automatic waters and bunk-style 
feeders, such that each lamb had a minimum of 38.1 cm of linear trough space and 6.97 
square meters of pen space.  A routine vaccination and anthelmintic schedule for all 
animals on trial was followed by farm management.  Lambs in this study were not in 
stalls, but were in pens where they were free to move around.  This enabled us to achieve 
levels of intake comparable to those observed in production studies.   
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Diets 
 Dietary treatments consisted of a commercially available growing ration 1) with 
(EXP) or 2) without (CON) the mannan oligosaccharide Bio-Mos® (Bio-Mos®, Alltech, 
Nicholasville, KY). Ingredients and nutrient composition are shown in Table 1.  The level 
of Bio-Mos® inclusion was consistent with manufacturer-recommended levels and was 
added at 0.50%.  Feed was delivered twice daily at 0800 hours (AM feeding) and 1600 
hours (PM feeding).  Feed was provided to appetite daily, feed refusals were collected 
and recorded daily.  Loose trace mineral and fresh water were available at all times. 
 
Table 1. Nutrient composition of control and Bio-Mos® growing ration on a DM basis. 
Item     Control   Bio-Mos 
Ingredients(%) 
Corn    38.57    38.37 
Dehy. Alfalfa 17%  30.27    30.07 
Soybean Hulls   12.26    12.16 
Cottonseed Meal  5.68    5.68 
Rice Bran   5.27    5.27 
Liquid Binder   2.50    2.50 
Feather Meal   1.50    1.50 
DDG (Solulac)   1.25    1.25 
Dried lignin   1.00    1.00 
Ammonium Chloride  0.60    0.60 
Bio-Mos   0.00    0.50 
Salt Mixing   0.50    0.50 
Urea 287   0.25    0.25 
Blood meal   0.25    0.25 
Deccox    0.06    0.06 
Beef Vit    0.03    0.03 
Sheep Fort   0.03    0.03 
 
Nutrient Content 
Crude Protein %  17.75    17.75 
Crude Fat %   4.44    4.44 
Crude Fiber %   15.41    15.41 
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Body Measurements 
 Lambs were weighed at the start of the trial (d 0), and on d 7, 14, 21, and 28.  
Lambs were weighed individually on an electronic digital walk-on scale prior to the AM 
feeding.  Temperatures were taken per rectum using a digital thermometer at the same 
times as weights.   
Fecal Samples 
Fecal grab samples were obtained per rectum at the same intervals as weighing. 
Fecal samples were collected in plastic bags, and transported to the laboratory for 
evaluation immediately following the conclusion of the weight collections.  
Fecal scores were assigned for each sample using a 5-point scale. The fecal scores 
were assigned based on the following criteria (1=firm, dry, well-formed pellet; 2=loose to 
firm, moist, well-formed individual pellet; 3=soft, moist pat with some indication of 
individual pellet formation, 4=soft, wet pat with no pellet formation; 5=diarrhea).   
   Following the rating of each sample for fecal score, pH was determined for each 
sample.  An electronic pH meter was used to determine values.  One gram of fecal 
material was placed in a 10 ml glass beaker and mixed using a plastic stirring rod with 
four ml of distilled water.  The distilled water/fecal material solution were mixed into a 
slurry of uniform consistency.  An electronic meter fitted with a glass electrode was used 
to measure slurry pH. 
Data Analysis 
 This experiment was analyzed as a completely randomized design with a factorial 
treatment arrangement.  Treatment factors are gender (ewes versus wethers) and diet 
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(Control versus Bio-Mos®).  Repeated measures were taken on the experimental units so 
that time becomes another factor. 
Each response variable was modeled using the effects of gender, diet, and the 
interaction of gender and diet, as repeated measures in time using the MIXED procedure 
of SAS (Version 9.1.3, SAS Institute, Cary, NC).  The subject of repeated measures (i.e., 
the experimental unit) was pen within the diet X gender combination.  The best fitting 
covariance structure according to Aikey’s Information Criterion was auto regressive with 
a lag of one.  The other type of structures that were tested were compound symmetry and 
unstructured.  Effects with probabilities less than p = 0.05 were considered significant.  
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RESULTS AND DISCUSSION 
All responses evaluated in this study were influenced by time (p < 0.05) over the 
28-d trial (Table 2). Lambs gained faster in week 2 than other weeks, and this increased 
rate of gain resulted in increases in feed efficiency. Intake increased over time.  Fecal pH 
appeared to cycle, increasing from week 1 to 2, decreasing from week 2 to 3, and then 
increasing again from week 3 to 4. Fecal consistency was firmer in week 3 compared to 
other weeks, but the magnitude of this change was small and does not appear to be 
related to feed intake or fecal pH.  Temperature was numerically higher during week 1 
and week 2 of the study and was lower for week 3 to 4.  This response in temperature 
may be due to lambs undergoing a higher degree of stress over the first half of the study.  
Over the second half of the study the lambs may have become more adapted to the 
environment.  As well, lambs were vaccinated prior to entering the study which may have 
caused an increase in temperature initially.  Alternatively, over the first weeks of the 
study the investigators were not as efficient in the handling of the lambs which may have 
increased the time to measure each individual lamb.  In turn, in the first two weeks the 
lambs may have been more stressed during handling, increasing temperature, and it may 
have been later in the morning by the completion of the measurements, increasing 
environmental temperature.   
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Table 2. Effect of time on weaned lambs fed Bio-Mos® diet or control diet. 
       Treatment 
 ______________________________________________________________________________ 
Item   Week 1  Week 2  Week 3  Week 4    SE 
ADG (g)  241.72a  481.62 b  272.93 a  232.24 a       29.292 
Gain:Feed   0.1932 a  0.3510 b  0.1665 a  0.1307 a      0.0186 
Intake(lamb/wk) (kg) 8.706 a  9.647 b  11.574 c  12.246d         0.1368 
pH   6.1313 a  6.3500 ab 6.0963 a  6.4250 b         0.0841 
Fecal Score  3.2838 ab 3.3288 a  2.9563 b  3.3625 a         0.1572 
Temperature(C)  39.706 ab 39.889 a  39.539 b  39.561 b         0.0723 
a,b,c,dMeans within a row with different subscripts differ; P < 0.05. 
 
ADG 
Diet, gender, and their interaction had minimal influence on ADG (p > 0.58). 
Growth responses to diet by week are shown in Table 3.   
 
Table 3. Growth performance of weaned lambs. 
Item    Control   Bio-Mos ®   SE 
Avg. initial wt (kg)  24.56   23.65 
Avg final wt (kg)   33.22   32.21 
Week 1 (d 0 to 7)    
     Daily gain/hd (g)    241.31   242.13    41.43 
      Intake(lamb/wk) (kg)  8.657   8.755    0.194 
     Gain:Feed   0.1862   0.1747    0.0263 
Week 2 (d 7 to 14) 
     Daily gain/hd (g)  463.93   499.31    41.43 
     Intake(lamb/wk) (kg)  10.091a   9.202 b    0.194 
     Gain:Feed   0.3182   0.3759    0.0263 
Week 3 (d 14 to 21) 
     Daily gain/hd (g)  301.64   244.26    41.43 
     Intake(lamb/wk)(kg)  11.693   11.454    0.194 
     Gain:Feed   0.1533   0.1238    0.0263 
Week 4 (d 21 to 28) 
     Daily gain/hd (g)  228.38   236.09    41.43 
     Intake(lamb/wk) (kg)  12.527   11.965    0.194 
     Gain:Feed   0.0823   0.0815    0.0263 
Entire Experiment (d 0 to 28) 
     Daily gain/hd (g)  308.81   305.45    15.663 
     Intake(lamb/wk) (kg)  10.742   10.344    0.132 
     Gain:Feed   0.1471   0.1393    0.009 
a,bMeans within a row with different subscripts differ; p < 0.05. 
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A GENDER × WEEK interaction was observed for ADG and feed conversion (p 
< 0.05; Table 4).  The interaction of time and gender appear mainly at week 3 and 4 
(Table 4), 
 
 
Table 4. Effect of GENDER × WEEK on weaned lamb growth performance. 
       Treatment 
 ______________________________________________________________________________ 
Ewe      Wether 
_____________________________________________________________________________________ 
    Week      Week 
Item      1                 2                 3                 4                 1                 2                 3                 4          SE  
ADG (g)   202.76a      491.24b          171.00a           347.32c         280.68a           471.96b         374.89bc        117.16a    0.091 
Gain:Feed  0.1573a       0.3571b         0.0979a        0.1786a        0.2111a           0.3331b         0.2281a   ,     0.053c  ,  0.026 
a,b,cMeans within a row with different subscripts differ; p < 0.05. 
 
where rank changes occurred.   
McClure et al. (2000) found cumulative ADG was greater for wethers than for 
ewes, similar to that reported in this study.  This lack of growth increase due to addition 
of Bio-Mos® contradicts Rozeboom et al. (2005) who reported that in a 42-d study Bio-
Mos® increased growth rate over the course of a study involving pigs.  Our finding that 
Bio-Mos® did not affect growth rate are in agreement with the investigation of weanling 
pigs with Bio-Mos® added to the ration by LeMieux et al. (2003). 
There are at least two possibilities why growth rate was not influenced by MOS 
supplementation, as suggested by Rozeboom et al. (2005).  First, it might be that the 
product decreased pathogenic challenges in the intestine, but growth rate was not a good 
indicator of the degree of the challenge.  Second, the response to the product observed in 
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other studies might have been due to other factors than protection against enteric 
pathogenic challenges. 
It was expected that the lambs fed Bio-Mos® would have increased growth rate 
due to enhanced gastrointestinal health.  Improving the overall intestinal health by 
binding potential pathogens and by enhancing the animal’s ability to defend against 
potential antigens by increasing the level of antibody titres, immunoglobins, and 
macrophage activity indicates a greater capacity to cope with potential diseases and will 
ultimately lead to better health and better growth performance (Rozeboom et al., 2005). 
Intake 
Control lambs tended (p = 0.10) to have a higher intake over the 28-d period in 
comparison to Bio-Mos® fed lambs (Table 3).  There were no statistically significant 
differences (p < 0.05) between control and Bio-Mos® fed lambs for any of the growth 
parameters that were measured. There was a tendency (p= 0.10) for GENDER × WEEK 
to influence intake (Table 4). Gender also tended to interacted with diet (GENDER × 
DIET, p = 0.09) to influence intake over the trial period.  Wether intake was similar for 
both diets (10.48 kg for controls vs. 10.52 kg for Bio-Mos®, SE=0.186), whereas ewe 
intake tended (p = 0.09) to be higher for control diet (10.98.± 0.186 kg) relative to the 
Bio-Mos® diet (10.18.±0 .186 kg).  A DIET × WEEK interaction significantly (p < 0.05) 
influenced intake over the course of the experiment (Table 3). 
Throughout the duration of the experiment, all the lambs performed well, all the 
pens progressed well from an intake standpoint and all pens gained weight.  In our study, 
growth was actually depressed when Bio-Mos® was included, apparently due to reduced 
feed intake.  This data is in agreement with a previous study performed by White et al. 
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(2002) in which growth performance was not enhanced by supplementing the basal diet 
with either brewers dried yeast alone or with the combination of yeast and citric acid.  
Pigs fed the two yeast-containing diets consumed less feed (p < 0.05), which resulted in 
reduced growth rates (p < 0.05) over the 28-d test period.   
Feed Conversion 
 A GENDER × WEEK interaction was observed (p < 0.05) for feed conversion 
(Table 4).  Treatment had little impact on feed conversion (p =0.80), Bio-Mos® fed 
lambs had a numerically lower gain:feed ratio compared to control fed lambs (Table 3).  
The data shows that the ewes exhibited poor feed conversion during week 3 while the 
remained relatively constant in their ability to convert feed.  However, during week 4 
ewes returned to a steady level, whereas wethers were poor converters.   
As expected, in the weeks where the lambs had a higher average daily gain they 
were more feed efficient and the inverse is true as well.  Overall, diet had little influence 
on the feed conversion of the lambs involved in the study.  This corresponds to the White 
et al. (2002) study in which feed:gain ratios tended to be inferior in the yeast-fed pigs 
during the initial phase of the experiment.  Rozeboom et al. (2005) showed variable feed 
efficiency responses; the MOS improved feed efficiency in a trial involving pigs from 
one location, but had no impact on efficiency in pigs from two other farms. 
Davis et al. (2004) performed a study similar to the present trial but using swine.  
These authors found that pigs fed diets including mannans had greater ADG and G:F than 
pigs fed the basal diet from d 0 to 14 post-weaning.  Although ADG, ADFI, and G:F 
were unaltered as a result of dietary treatment from d 14 to 21 post weaning, the 
improvement in ADG and G:F was maintained in the overall experiment.  This was 
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reflected by the greater BW of pigs fed mannans on d 14 and 21 of the experiment 
compared with pigs fed the basal diet. 
In the present study it was expected that the Bio-Mos® fed lambs would have 
enhanced gain, efficiency, and intake relative to the control diet; however, minimal 
effects of MOS were observed.  Previous trials have been variable in other species. In 
some mannan oligosaccharides show little effect on growth responses, in others a large 
effect has been observed.  The addition of phosphorylated mannans to weanling pig diets 
has been reported to increase gain and feed intake (Kim et al., 2000; Davis et al., 2002).  
In contrast, other work has reported no benefit when adding mannans to weanling pig 
diets when compared with a positive-control diet with antibiotics or a negative control 
diet devoid of antibiotics (Ko et al., 1998). Studies involving dairy calves reported no 
differences in feed intake and growth with the inclusion of Bio-Mos® as a part of the calf 
diet (Donovan et al., 2002; Heinrichs et al., 2003). These inconsistent responses to 
mannan supplementation may be because of varying environmental conditions and health 
status within herds.  The improvement in growth performance from mannan addition may 
be greater when it is supplemented to slower-growing pigs, where slow growth is 
speculated to be indicative of herd health challenges (Pettigrew, 2000).   
The mechanism for improved feed efficiency observed by lambs whose intake is 
restricted is not attributable to changes in diet digestibility or ruminal characteristics 
(Hart and Glimp, 1991).  Possibly, a reduction in the size of the liver and (or) the small 
intestine reduces the maintenance requirement of the animal (Baldwin et al., 1980).  Also, 
the efficiency at which energy  is metabolized may be affected  by the differences in 
feeding patterns (lambs on restricted intake regimens tend to consume the majority of 
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their feed within 4 h of feeding, whereas animals given ad libitum access to feed consume 
feed throughout the day).  Ferrell (1988) and Koong et al. (1985) have shown animals fed 
at high levels have higher liver and small intestine weights than animals with lower levels 
of intake.  Animals on the high intake regimen also had higher maintenance energy 
requirements. 
Health Parameters 
All health parameters were within normal limits throughout this study indicating 
that these lambs were under low stress, which may have influenced the effect of the 
additive.  The weaned lambs in the present study maintained good health status both prior 
to and after the experiment, indicating that this group of lambs either already had high 
immune function or experienced minimum disease challenge, which might limit the 
potential growth response to MOS.  The health parameters throughout the study are 
shown in Table 5. 
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Table 5.  Health parameters of weaned lambs. 
Item    Control   Bio-Mos ®   SE 
Week 1 (d 0 to 7) 
     Temperature (C) 
 Ewes   39.77   39.74    0.0723 
 Wethers   39.70   39.61    0.0723 
     Fecal pH   6.2700   5.9925    0.1191 
     Fecal Score   3.2600   3.3075    0.2223 
Week 2 (d 7 to 14) 
     Temperature 
 Ewes   39.88   39.69    0.0723 
 Wethers   39.92   40.08    0.0723 
     Fecal pH   6.5900   6.1100    0.1191 
     Fecal Score   3.3075   3.3500    0.2223 
Week 3 (d 14 to 21) 
     Temperature 
 Ewes   39.59   39.54    0.0723 
 Wethers   39.40   39.63    0.0723 
     Fecal pH   6.2500   5.9425    0.1191 
     Fecal Score   2.9000   3.0125    0.2223 
Week 4 (d 21 to 28) 
     Temperature 
 Ewes   39.44   39.62    0.0723 
 Wethers   39.74   39.44    0.0723 
     Fecal pH   6.5350   6.3150    0.1191 
     Fecal Score   3.3675   3.3575    0.2223 
Entire Experiment (d 0 to 28) 
     Temperature   39.68   39.67                  0.0699 
     Fecal pH   6.4113a   6.0900b    0.0648 
     Fecal Score   3.2088   3.2569    0.1626 
a,bMeans within a row with different subscripts differ; p < 0.05. 
 
Temperature 
Rectal temperatures of the lambs being studied varied only with week (p < 0.05).  
Other variables did not affect temperature (p > 0.20).  Rectal temperature was evaluated 
as an indicator of clinical health status of the lambs.  The time effect could possibly be 
due to differences in the weather and external temperature over the course of the trial 
period.  However, each pen was equipped with large circulating fans to combat this issue, 
and all temperatures were taken by 1100 hours on each collection day. 
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Fecal Score 
 Time was the only factor that statistically affected (p < 0.05) fecal score over the 
trial period.  According to the scale used in this study, a lower fecal score would indicate 
improved gut health.  Very few lambs on any treatment had severity scores of 5.  Fecal 
scores were lower (less fluidity) during week 3 of the study.  At this point it is speculated 
that the lambs may have been more accustomed to their respective diets, and as their 
gastrointestinal tracts continue to mature they are better able to digest the high 
concentrate diets.  This may explain the decrease in fecal fluidity.  However, with a large 
increase in intake over the last two weeks of the studies, the increase in fecal scores over 
the last week of the study may have been a response to increasing feed intake. 
 Heinrichs et al. (2003) showed an antibiotic and MOS treatments had a higher 
overall probability of normal feces throughout a study with dairy calves.  A large 
majority of calves showed some degree of increased fecal fluidity during the first 2 wk of 
age, this may be a similar situation to placing weaned lambs directly on a high 
concentrate diet.  In the present study the addition of Bio-Mos® to the diet had no effect 
on fecal score, and is reflected in the time effect observed.   
Fecal pH  
Diet influenced fecal pH (p < 0.05).  The Bio-Mos® fed lambs had a more acidic 
fecal pH compared to controls.  Fecal pH also varied with week of the trial (p < 0.05).  
Fecal pH was analyzed as an indication of gastrointestinal tract fermentation patterns.   
In the White et al. (2002) study, the authors found fecal pH showed only minor 
changes occurring in the feces of pigs fed the four diets.  However, in that study the yeast 
diet had a more basic pH as compared to control diet, which contradicts data in the 
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present study.  Hart and Glimp (1991) reported ruminal pH values that could be used as a 
comparison to those in the present study, in that case ruminal pH was lower for the higher 
concentrate diets following the increase in total concentration of VFA.  Ruminal pH was 
5.45 for pelleted concentrate versus 5.62 for whole shelled corn diets.  It is possible that 
the pH value for Bio-Mos fed lambs in the present study is more acidic due to an increase 
in VFA production in the gastrointestinal tract of the lambs.  However, this conflicted 
with a Smiricky-Tjardes (2003) study which found that when comparing many 
oligosaccharides present in feed ingredients tested at the 12 h fermentation time, manna 
oligosaccharide fermentation produced the least amounts of acetate and propionate when 
compared to all other substrates.  In this cited trial however, there is no comparison to a 
non-oligosaccharide.  In our study, because the control lambs tended to have a higher 
intake, it is less likely that the pH shift was because of increased VFA production. 
The inclusion of yeast into the diet has been shown to reduce lactate production in 
ruminants (Quigley et al., 1992), potentially reducing the effects of lactic acidosis in 
ruminants consuming high concentrate diets. However, the lack of observation of 
symptoms of acidosis in either treatment group and the more acidic fecal pH observed in 
lambs fed MOS suggest that there was no reduction in acid production due to feeding 
MOS. 
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CONCLUSIONS 
This study indicates that the addition of Bio-Mos® to the diet of weaned lambs 
had minimal influence on the growth and performance of the lambs.  Bio-Mos® addition 
to the diet had little impact on the health parameters of the lambs utilized in the study.  
However, fecal pH was influenced by the Bio-Mos® diet, making those fecal samples 
have a more acidic pH.  This may be due to an increase in VFA production.  The animals 
used in this study had normal health parameters, which may imply that these lambs were 
under low stress and may have influenced the affects of the Bio-Mos® addition.  Lambs 
in this study were never subjected to a challenging environment, as lambs were never 
transported or exposed to new pathogens.  It is possible that if lambs had been relocated 
to a new environment the influence of Bio-Mos® would have been greater.  Another 
possibility is that Bio-Mos® has no influence on growing lambs when supplemented in 
the diet. It is determined that more investigation is necessary to determine if different 
levels of Bio-Mos® would impact the lamb performance.  It may be necessary to stress 
challenge the lambs over the course of the study to induce more enhancement from the 
additive.   
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